Israeli Researchers Develop Highly Accurate Early Breast Cancer Blood Test
Summarized from The Times of Israel by baba
Israeli researchers have developed an experimental blood test that detects early-stage breast cancer with 95% accuracy for tumors under two centimeters. The test, which analyzes epigenetic markers, also predicts recurrence risk with 81% accuracy. Published in Nature, the study involved international collaboration and could lead to new therapies targeting cancer's epigenetic flexibility.
The story in 6 lines · by baba
- An experimental blood test developed by Israeli researchers detects early breast cancer with 95% accuracy.
- The test analyzes epigenetic markers to identify aggressive cancer cells and predict recurrence risk.
- It achieved 81% accuracy in distinguishing between patients who experienced cancer recurrence and those who did not.
- The research was a collaboration between the Weizmann Institute of Science and Hebrew University.
- The findings were published in the prestigious scientific journal Nature.
- The test's accuracy is not affected by breast density, a limitation of mammograms.
The Times of Israel publishes in English. The key points are summarized above. Read The Times of Israel’s full report from the link at the top of the page.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 2
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
